John Varga, MD

John Varga, MD

Specialty: Rheumatology, Internal Medicine
Title: Professor
4.7/5
See All Ratings

Accepts most insurance plans

To request an appointment call

888-229-3065
John Varga, MD
John Varga, MD
Rheumatology
  • Expertise
  • Locations
  • Insurance
  • Education & Training
  • Patient Ratings & Comments
  • Manage Your Profile

  • Locations

    • Rheumatology Clinic | Taubman Center 1500 E Medical Center Dr
      Floor 3 Reception A
      Ann Arbor, MI 48109-5358
      Get Directions

    Insurance Accepted

    University of Michigan Health participates with most health insurance plans.

    See our insurance details

    Education & Training

    Medical School or Training

    New York University School of Medicine, 1980

    Residency

    Rhode Island Hospital, Internal Medicine, 1983

    Fellowships

    Boston University Medical Center, Rheumatology, 1985

    Board Certifications

    Internal Medicine
    Rheumatology

    Patient Ratings & Comments

    Visit our Physician Ratings & Comments page to learn more about how patient ratings are collected, calculated, and updated to help you make an informed decision when choosing the right physician for your care.

    Patient Ratings

    83 Patient Ratings

    Patient Comments

    December 5, 2025 - "I respect Dr. Varga completely. He listens carefully to my concerns, will answer all my questions and is able to share his thoughts/treatments completely with me."

    September 25, 2025 - "Dr. Varga gave me his undivided attention, was patient, listened to and addressed my concerns, was personable, was detail-oriented and provided thorough explanations, provided options, and included me in the decision-making process."

    July 25, 2025 - "I am very pleased with being Dr Varga's patient. He's very knowledgeable about [...], asks me questions so he has a better understanding of my happenings, he's patient and kind. I trust him."

    Featured News & Stories

    scratching arm pink sweater in living room teal couch
    Health Lab

    A metabolic “switch” that could help reset scar-producing cells in scleroderma

    Researchers at University of Michigan Health and collaborating institutions have identified a metabolic enzyme that may offer a fundamentally new way to attack one of the most difficult-to-treat features of systemic sclerosis, or scleroderma: progressive and potentially life threatening tissue scarring.
    microscope
    Health Lab

    Antibody targeting CD38 enzyme shows positive impact in treating systemic sclerosis

    Using the Ab38 antibody to target the CD38 enzyme could be a new gateway to treat and prevent fibrosis for patients with systemic sclerosis.